APCM Implementation Checklist for Depression & Anxiety

Confirm patients have two or more chronic conditions, including depression or anxiety, and meet the 2026 G0568-G0570 requirements.

Modify electronic health records to systematically capture and trend PHQ-9 and GAD-7 scores for MIPS quality reporting.

Establish a written agreement with a psychiatric consultant to review treatment-resistant cases as required by BHI regulations.

Ensure your revenue cycle management system is updated to recognize G0568 through G0570 for additional behavioral health revenue.

Develop a standardized documentation process for high-risk PHQ-9 responses (Question 9) to ensure HIPAA and safety compliance.

Set a clinical cadence for screening, typically every 30-90 days, to monitor treatment efficacy and adjust care plans.

Create a clinical pathway for patients who fail to respond to two or more antidepressant trials within the APCM program.

Ensure that behavioral health care managers are tracking psychotherapy attendance and integrating therapist notes into the care plan.

Record all dosage adjustments, side effect profiles, and adherence discussions for SSRIs, SNRIs, and other psychotropics.

Explicitly link depression management to outcomes for comorbid conditions like diabetes or chronic heart disease in the care plan.

Deploy AI voice assistants to call patients and record screening scores, automatically pushing the data into the patient's record.

Use AI-driven phone outreach to check if patients are taking antidepressants as prescribed and identify barriers to adherence.

Program AI call handlers to immediately alert a human care manager if a patient reports a significant increase in depressive symptoms.

Enable AI to handle inbound and outbound calls for scheduling behavioral health appointments, reducing no-show rates.

Use automated voice responses to provide immediate information on common side effects of anxiolytics and antidepressants.